Common alternative gene alterations in adult malignant astrocytomas, but not in childhood primitive neuroectodermal tumors: P16ink4 homozygous deletions and CDK4 gene amplifications

Journal of Neurosurgery

Volumn 84, Issue 6, 1996, Pages 1020-1023

  Petronio, Joseph ^a   He, Ju ^b   Fults, Daniel ^b   Pedone, Carolyn ^b   James, C David ^b   Allen, James R ^b  

^a EMORY CLINIC   (United States)

^b NONE

Author keywords

cyclin; cyclin dependent kinase; oncogene; retinoblastoma protein; tumor suppressor

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; GENE PRODUCT; LIGAND; RETINOBLASTOMA PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; DNA HYBRIDIZATION; GENE AMPLIFICATION; GENE DELETION; GENE FREQUENCY; HUMAN; HUMAN TISSUE; INFANT; NEUROECTODERM TUMOR; ONCOGENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0029952258     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1996.84.6.1020     Document Type: Article

References (25)

1. Buckley MF, Sweeney KJE, Hamilton JA, et al: Expression and amplification of cyclin genes in human breast cancer. Oncogene 8:2127-2133, 1993
2. Burger PC, Vogel FS, Green SB, et al: Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 56:1106-1111, 1985
3. Caldas C, Hahn SA, da Costa LT, et al: Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 8:27-32, 1994
4. Cheng JQ, Jhanwar SC, Klein WM, et al: p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res 54:5547-5551, 1994
5. Fountain JW, Karayiorgou M, Taruscio D, et al: Genetic and physical map of the interferon region on chromosome 9p. Genomics 14:105-112, 1992
6. Fults D, Redone CA, Thomas GA. et al: Allelotype of human malignant astrocytoma. Cancer Res 50:5784-5789, 1990
7. Giani C, Finocchiaro G: Mutation rate of the CDKN2 gene in malignant gliomas. Cancer Res 54:6338-6339, 1994
8. Hamel PA, Phillips RA, Muncaster M, et al: Speculations on the roles of RB1 in tissue-specific differentiation, tumor initiation, and tumor progression. FASEB J 7:846-854, 1993
9. He J, Allen JR, Collins VP, et al: CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. Cancer Res 54:5804-5807, 1994
10. Henson JW, Schnitker BL, Correa KM, et al: The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 36:714-721, 1994
11. Hinds PW, Weinberg RA: Tumor suppressor genes. Curr Opin Genet Dev 4:135-141, 1994
12. James CD, He J, Carlbom E, et al: Chromosome 9 deletion mapping reveals interferon α and Interferon β-1 gene deletions in human glial tumors. Cancer Res 51:1684-1688, 1991
13. James CD, He J, Collins VP, et al: Localization of chromosome 9p homozygous deletions in glioma cell lines with markers constituting a continuous linkage group. Cancer Res 53: 3674-3676, 1993
14. Jen J, Harper JW, Bigner SH, et al: Deletion of p16 and p15 genes in brain tumors. Cancer Res 54:6353-6358, 1994
15. Jiang W, Kahn SM, Tomita N, et al: Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res 52:2980-2983, 1992
16. Kamb A, Gruis NA, Weaver-Feldhaus J, et al: A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440, 1994
17. Kato J, Matsushime H, Hiebert SW, et al: Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 7:331-342, 1993
18. Khatib ZA, Matsushime H, Valentine M, et al: Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res 53:5535-5541, 1993
19. Nobori T, Miura K, Wu DJ, et al: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368:753-756, 1994
20. Olopade OI, Jenkins RB, Ransom DT, et al: Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res 52:2523-2529, 1992
21. Quesnel B, Preudhomme C, Philippe N, et al: p 16 gene homozygous deletions in acute lymphoblastic leukemia. Blood 85: 657-663, 1995
22. Schmidt EE, Ichimura K, Reifenberger G, et al: CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 54:6321-6324, 1994
23. Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704-707, 1993
24. Washimi O, Nagatake M, Osada H, et al: In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in non-small cell lung cancers. Cancer Res 55:514-517, 1995
25. Zhang YJ, Jiang W, Chen CJ, et al: Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun 196:1010-1016, 1993